Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 75 years
- People who have given their signed agreement to take part
- People living with long-term (more than 12 months) neuropathic pain on one side of the body caused by a stroke (either a blocked or bleeding blood vessel in the brain)
- People living with long-term (more than 12 months) neuropathic facial pain on one side of the face caused by one of the following: shingles (post-herpetic neuralgia), a physical injury to a nerve in the face, or atypical trigeminal neuralgia that developed after a surgical procedure
- People whose pain is severe (rated above 6 out of 10) and has not responded adequately to medication for nerve pain, including at least anti-seizure medications and antidepressants, tried at appropriate doses and for sufficient periods of time
Who may not be able to join:
- People with significant problems with memory or thinking (as measured by a standard cognitive test)
- People with a diagnosed psychiatric condition (as defined by the DSM-IV diagnostic system, covering a range of mental health disorders) (confirm with trial site)
- People with certain psychosocial risk factors, including a history of other long-term pain conditions, a pattern of catastrophic thinking about pain, substance misuse, or situations where there may be personal benefit from remaining in pain
- People for whom surgery, anaesthesia, or MRI scanning would not be medically safe
- People who are unlikely or unable to properly operate the deep brain stimulation (DBS) device used in this trial
- Women who are able to become pregnant
- People who are unable to follow the study procedures due to language barriers, psychological difficulties, dementia, or similar reasons
- People who have taken part in another interventional clinical trial in the 30 days before this trial, or who are currently in another such trial
- People who have previously been enrolled in this same trial
- Family members, employees, or other dependants of the researchers running the trial
- People who are expected to need diathermy (a heat-based medical treatment), electroshock therapy, or transcranial magnetic stimulation (TMS)
- People who already have an electrical device implanted in their body, such as a cardiac defibrillator or pacemaker
- People considered to be at high risk from surgery, for example due to multiple serious illnesses or an active widespread infection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andreas Nowacki, MD, Insel Gruppe AG, University Hospital Bern
Phone: +41 31 6320014
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage reduction of pain intensity; Percentage reduction of pain intensity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.